Summary & Overview
CPT 86648: Diphtheria Antitoxoid Antibody Immunoassay
CPT code 86648 designates a laboratory immunoassay for diphtheria antitoxoid antibody, used to assess immune status after vaccination or possible exposure to Corynebacterium diphtheriae. Nationally, this serologic test supports clinical decision-making for prophylaxis, booster vaccination needs, and diagnosis in suspected cases, making it relevant to public health, primary care, and infectious disease management. Key payers commonly covering this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise review of what CPT code 86648 represents, typical clinical contexts for ordering the test, and the settings where the service is delivered. The publication outlines common payer coverage considerations and common modifiers used in laboratory billing (reference only), and highlights diagnostic and clinical context for interpretation. Benchmarks, reimbursement trends, and policy updates are summarized to inform administrative and clinical stakeholders about coding practice, billing variants, and documentation that supports medical necessity. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 86648 describes an immunoassay performed to evaluate a patient’s blood for diphtheria antitoxoid antibody. The procedure is a laboratory serologic test that measures antibody levels to determine immune status or response to vaccination or suspected exposure.
-
Service type: Laboratory antibody immunoassay
-
Typical site of service: Clinical laboratory or hospital laboratory service (specimen collected in outpatient clinic, hospital, or public health setting as appropriate)
Clinical & Coding Specifications
Clinical Context
A 34-year-old adult presents to an outpatient laboratory following recent travel and documentation of uncertain diphtheria immunization history. The clinician orders a serum diphtheria antitoxoid antibody immunoassay to determine immune status. The phlebotomist collects a blood sample in the laboratory draw station; the specimen is processed by the clinical laboratory scientist, who performs an immunoassay to quantify antitoxin levels. Results are reported to the ordering provider to support decisions about booster immunization or post-exposure management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing only the physician or qualified professional interpretation of the laboratory result (rare for immunoassays). |
59 | Distinct procedural service | When this immunoassay is distinct and separate from another laboratory service provided on the same date. |
90 |